Search research articles
Contact Us
Filters
Showing results (1-10 of 1,139) with videos related to
Page
of 114
Sort By:
Current Drug Metabolism
|
May 14, 2008
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4
Shu-Feng Zhou
Clinical Pharmacokinetics
|
October 13, 2009
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I
Shu-Feng Zhou
The New England Journal of Medicine
|
June 19, 2007
ERCC1 and non-small-cell lung cancer
Shu-Feng Zhou
Clinical Pharmacokinetics
|
November 12, 2009
Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II
Shu-Feng Zhou
Drug Design, Development and Therapy
|
August 1, 2015
Functional magnetic resonance imaging is a powerful approach to probing the mechanism of action of therapeutic drugs that act on the central nervous system
Shu-Feng Zhou
Current Pharmaceutical Design
|
May 14, 2008
Potential strategies for minimizing mechanism-based inhibition of cytochrome P450 3A4
Shu-Feng Zhou
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
May 30, 2007
HLA polymorphisms and genetic markers for traditional Chinese medicine
Shu-Feng Zhou
Hu Li Za Zhi the Journal of Nursing
|
January 22, 2024
[ICOPE Evaluations and Promoting Health in Older Adults: A Chinese Medicine Perspective]
Shu-Feng Tsai
Clinical Laboratory
|
April 14, 2023
Clinical and Microbiological Characteristics of Type 2 Diabetes Mellitus Accompanied with Sepsis
Shu Feng, Jie Zhang
World Journal of Gastroenterology
|
January 31, 2002
Comparative ultrastructural study of endoplasmic reticulum in colorectal carcinoma cell lines with different degrees of differentiation
Shu Feng, Jin-Dan Song
Page
of 114
Search research articles
Search
Showing results (1-10 of 1,139) with videos related to
Sort By:
Page
of 114
Current Drug Metabolism
|
May 14, 2008
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4
Shu-Feng Zhou
Clinical Pharmacokinetics
|
October 13, 2009
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I
Shu-Feng Zhou
The New England Journal of Medicine
|
June 19, 2007
ERCC1 and non-small-cell lung cancer
Shu-Feng Zhou
Clinical Pharmacokinetics
|
November 12, 2009
Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II
Shu-Feng Zhou
Drug Design, Development and Therapy
|
August 1, 2015
Functional magnetic resonance imaging is a powerful approach to probing the mechanism of action of therapeutic drugs that act on the central nervous system
Shu-Feng Zhou
Current Pharmaceutical Design
|
May 14, 2008
Potential strategies for minimizing mechanism-based inhibition of cytochrome P450 3A4
Shu-Feng Zhou
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
May 30, 2007
HLA polymorphisms and genetic markers for traditional Chinese medicine
Shu-Feng Zhou
Hu Li Za Zhi the Journal of Nursing
|
January 22, 2024
[ICOPE Evaluations and Promoting Health in Older Adults: A Chinese Medicine Perspective]
Shu-Feng Tsai
Clinical Laboratory
|
April 14, 2023
Clinical and Microbiological Characteristics of Type 2 Diabetes Mellitus Accompanied with Sepsis
Shu Feng, Jie Zhang
World Journal of Gastroenterology
|
January 31, 2002
Comparative ultrastructural study of endoplasmic reticulum in colorectal carcinoma cell lines with different degrees of differentiation
Shu Feng, Jin-Dan Song
Page
of 114